Porton Pharmasolutions Denmark ApS: Financial statements 2023
CVR: 43082671
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Porton Pharmasolutions Denmark ApS (CVR 43082671) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -282,057 and a net result of DKK -3,327,784 compared with DKK -3,068,330 the year before. Equity in the 2023 report amounted to DKK -2,396,114. The company had 1 employee in the financial year.
- Gross Profit
- DKK -282,057
- Profit/Loss
- DKK -3,327,784
- Equity
- DKK -2,396,114
- Total Assets
- DKK 5,942,954
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -282K | -3.3M | -2.4M | 1 |
| 2022 | - | -959K | -3.1M | 932K | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Porton Pharmasolutions Denmark ApS has published its interim report for the period February 18, 2022 to December 31, 2022.
About Porton Pharmasolutions Denmark ApS
Porton Pharmasolutions Denmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Pavlos Kouroupis. The company is owned by Porton Pharmaceutical Chemicals GmbH. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 2,705,608 and a net result of DKK 94,702 compared with DKK -1,682,051 the year before. Equity in the 2025 report amounted to DKK -3,983,464.